Today's Morning Movers and Top Ratings: AMZN, NVO, NVDA, BAC and More

$Amazon (AMZN.US)$ stock increased by 0.13% after the company unveiled a new $79 Echo Spot alarm clock featuring a refreshed design and enhanced audio quality.

$Intel (INTC.US)$ stock leapt 2.68% following a previous session gain of over 6%, with Nvidia also up 1.57% and Marvell rising by 0.69%, as AI-associated stocks continued to gain favor.

$Pfizer (PFE.US)$ stock inched up by 0.18% on the news that its chief scientific officer, Mikael Dolsten, would be stepping down after more than a 15-year tenure with the pharmaceutical company.

$Eli Lilly and Co (LLY.US)$ stock advanced 0.82% following a data analysis revealing that its Mounjaro treatment results in quicker and more significant weight loss compared to Novo Nordisk's obesity drug Wegovy.

$Bank of America (BAC.US)$ was upgraded from Underweight to Neutral by Piper Sandler. Shares rose by 0.86% in premarket trading.

$Novo-Nordisk A/S (NVO.US)$ stock declined by 1.59% amid reports that Eli Lilly's Mounjaro treatment is more effective in weight loss than its Wegovy drug.

$Lucid Group (LCID.US)$ Group stock dropped 0.35% after the company announced a recall of over 5,000 of its 2022-2023 Air luxury sedans due to a software glitch that may lead to power loss.

$Helen Of Troy (HELE.US)$ stock plummeted 24.73% after the consumer products firm reported disappointing first-quarter earnings and significantly reduced its full-year forecast, particularly citing struggles in its beauty and wellness segments.